Early Diagnosis and Treatment of Pancreatic Dysplasia in Patients with a Family History of Pancreatic Cancer
- 17 August 1999
- journal article
- Published by American College of Physicians in Annals of Internal Medicine
- Vol. 131 (4), 247-255
- https://doi.org/10.7326/0003-4819-131-4-199908170-00003
Abstract
Pancreatic cancer, the fourth most common cause of cancer death in the United States, is hereditary in an estimated 10% of cases. Surveillance of patients with a familial predisposition for pancreatic cancer has not been systematically evaluated. To develop a surveillance program that can identify and treat patients who have precancerous conditions of the pancreas and a family history of pancreatic cancer. Prospective cohort study. University medical center. 14 patients from three kindreds with a history of pancreatic cancer. Endoscopic ultrasonography, endoscopic retrograde cholangiopancreatography (ERCP), spiral computed tomography, and serum carcinoembryonic antigen and CA19-9 analysis were performed in all patients. Four affected patients were tested for the K- ras mutation. Pancreatic dysplasia was determined by histologic evaluation. Seven of the 14 patients were believed to have dysplasia on the basis of clinical history and abnormalities on endoscopic ultrasonography and ERCP and were referred for pancreatectomy. All 7 patients had histologic evidence of dysplasia in pancreatectomy specimens. Findings on endoscopic ultrasonography were subtle, nonspecific, and similar to those seen in patients with chronic pancreatitis. Findings on ERCP ranged from mild and focal side-branch duct irregularities and small sacculations to main-duct strictures and grapelike clusters of saccules. Some of these changes are typical of chronic pancreatitis, but others are more distinctive. Spiral computed tomography and serum tumor markers had low sensitivity in the detection of pancreatic dysplasia. Analysis for the K- ras mutation yielded positive results in 3 of 4 patients with dysplasia. Thorough screening of patients with a family history of pancreatic cancer is feasible. Clinical data combined with imaging studies (endoscopic ultrasonography and ERCP) can be used to identify high-risk patients who have dysplasia. The role of molecular genetic testing is uncertain at this time.Keywords
This publication has 9 references indexed in Scilit:
- CancerPublished by Wiley ,2014
- Progression of Pancreatic Intraductal Neoplasias to Infiltrating Adenocarcinoma of the PancreasThe American Journal of Surgical Pathology, 1998
- Cancer statistics, 1998CA: A Cancer Journal for Clinicians, 1998
- Familial pancreatic adenocarcinoma: association with diabetes and early molecular diagnosis.Journal of Medical Genetics, 1995
- Investigational strategies for detection and intervention in early-stage pancreatic cancerJournal of Gastrointestinal Cancer, 1994
- Pancreatic CarcinomaNew England Journal of Medicine, 1992
- Intraductal proliferation in the pancreas and its relationship to human and experimental carcinogenesisVirchows Archiv, 1980
- Pathology of the Gastro-Intestinal TractPublished by Springer Science and Business Media LLC ,1976
- HETEROTOPIC PANCREATIC TISSUEArchives of Surgery, 1950